Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow

Blood

Volumn 118, Issue 7, 2011, Pages 1838-1844

  Matthes, Thomas ^a   Dunand Sauthier, Isabelle ^a   Santiago Raber, Marie Laure ^a   Krause, Karl Heinz ^a   Donze, Olivier ^b   Passweg, Jakob ^a,c   McKee, Tomas ^a   Huard, Bertrand ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Adipogen   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; CD135 ANTIGEN; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL MATURATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL;

EID: 80051875762     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-332940     Document Type: Article

References (40)

1. Sze D.M., Toellner K.M., Garcia de Vinuesa C., Taylor D.R., MacLennan I.C. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med. 2000;192(6):813-821.
2. Slifka M.K., Matloubian M., Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol. 1995;69(3):1895-1902.
3. Manz R.A., Thiel A., Radbruch A. Lifetime of plasma cells in the bone marrow. Nature. 1997;388(6638):133-134. (Pubitemid 27297440)
4. Tokoyoda K., Egawa T., Sugiyama T., Choi B.I., Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004;20(6):707-718. (Pubitemid 38757441)
5. Tokoyoda K., Hauser A.E., Nakayama T., Radbruch A. Organization of immunological memory by bone marrow stroma. Nat Rev Immunol. 2010;10(3):193-200.
6. Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: A tutorial on B cell survival. Annu Rev Immunol. 2003;21:231-264. (Pubitemid 37174532)
7. O'Connor B.P., Raman V.S., Erickson L.D., et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2004;199(1):91-98.
8. Huard B., McKee T., Bosshard C., et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest. 2008;118(8):2887-2895.
9. Bossen C., Cachero T.G., Tardivel A., et al. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood. 2008;111(3):1004-1012. (Pubitemid 351213377)
10. Belnoue E., Pihlgren M., McGaha T.L., et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood. 2008;111(5):2755-2764.
11. Castigli E., Scott S., Dedeoglu F., et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A. 2004;101(11):3903-3908. (Pubitemid 38381075)
12. Benson M.J., Dillon S.R., Castigli E., et al. Cutting edge: The dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol. 2008;180(6):3655-3659.
13. Kalled S.L., Ambrose C., Hsu Y.M. The biochemistry and biology of BAFF, APRIL and their receptors. Curr Dir Autoimmun. 2005;8:206-242.
14. Ingold K., Zumsteg A., Tardivel A., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med. 2005;201(9):1375-1383. (Pubitemid 40664082)
15. Hendriks J., Planelles L., De Jong-Odding J., et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 2005;12(6):637-648. (Pubitemid 40767166)
16. Wijdenes J., Vooijs W.C., Clement C., et al. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol. 1996;94(2):318-323. (Pubitemid 26247990)
17. Winter O., Moser K., Mohr E., et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 2010;116(11):1867-1875.
18. Chu V.T., Frohlich A., Steinhauser G., et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12(2):151-159.
19. Bonci D., Hahne M., Felli N., Peschle C., De Maria R. Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis. Blood. 2004;104(10):3169-3172. (Pubitemid 39507131)
20. Moreaux J., Cremer F.W., Reme T., et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood. 2005;106(3):1021-1030. (Pubitemid 41076449)
21. Yaccoby S., Pennisi A., Li X., et al. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Leukemia. 2008;22(2):406-413. (Pubitemid 351250547)
22. Ramirez J.M., Schaad O., Durual S., et al. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. Br J Haematol. 2009;144(2):251-262.
23. Schwaller J., Schneider P., Mhawech-Fauceglia P., et al. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood. 2007;109(1):331-338. (Pubitemid 46053074)
24. Arlettaz L., Degermann S., De Rham C., Roosnek E., Huard B. Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacity. Eur J Immunol. 2004;34(12):3413-3422. (Pubitemid 40012160)
25. Mhawech-Fauceglia P., Kaya G., Sauter G., et al. The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol. 2006;80(4):697-704. (Pubitemid 44835884)
26. Schwaller J., Went P., Matthes T., et al. Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease. Leukemia. 2007;21(6):1324-1327. (Pubitemid 46831829)
27. David G., Bai X.M., Van der Schueren B., Cassiman J.J., Van den Berghe H. Developmental changes in heparan sulfate expression: In situ detection with mAbs. J Cell Biol. 1992;119(4):961-975.
28. Krilis S.A., Austen K.F., Macpherson J.L., Nicodemus C.F., Gurish M.F., Stevens R.L. Continuous release of secretory granule proteoglycans from a cell strain derived from the bone marrow of a patient with diffuse cutaneous mastocytosis. Blood. 1992;79(1):144-151.
29. Gabay C., Krenn V., Bosshard C., Seemayer C.A., Chizzolini C., Huard B. Synovial tissues concentrate secreted APRIL. Arthritis Res Ther. 2009;11(5):R144.
30. Van Lochem E.G., Van der Velden V.H.J., Wind H.K., et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin Cytom. 2004;60(1):1-13. (Pubitemid 38885703)
31. López-Fraga M., Fernandez R., Albar J.P., Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001;2(10):945-951. (Pubitemid 33040585)
32. Scheding S., Meister B., Buhring H.J., et al. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells. Exp Hematol. 2000;28(4):460-470. (Pubitemid 30214158)
33. Barreda D.R., Hanington P.C., Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol. 2004;28(5):509-554. (Pubitemid 38177451)
34. Ueda Y., Kondo M., Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med. 2005;201(11):1771- 1780. (Pubitemid 41002896)
35. Chervenick P.A., Boggs D.R., Marsh J.C., Cartwright G.E., Wintrobe M.M. Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol. 1968;215(2):353-360.
36. Burjanadze M., Matthes T., McKee T., Passweg J., Huard B. In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development. Histol Histopathol. 2009;24(8):1061-1066.
37. Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010;33(5):657-670.
38. Brandtzaeg P., Johansen F.E. Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32-63. (Pubitemid 41105162)
39. Slifka M.K., Antia R., Whitmire J.K., Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 1998;8(3):363-372. (Pubitemid 28188896)
40. Slifka M.K., Ahmed R. Long-term humoral immunity against viruses: Revisiting the issue of plasma cell longevity. Trends Microbiol. 1996;4(10):394-400. (Pubitemid 26325130)